The effects of caffeic acid phenethyl ester (CAPE) on bacterial translocation and inflammatory response in an experimental intestinal obstruction model in rats

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 10, 2015, Pages 1907-1914

  Firat, U ^a   Senol, S ^b   Gelincik, I ^c   Kapan, M ^a   Tokgoz, O ^a   Tekin, R ^a   Evliyaoglu, O ^a   Onder, A ^a   Alp, H ^d  

^a DICLE UNIVERSITY   (Turkey)

^b ISTANBUL MEDENIYET UNIVERSITY   (Turkey)

^c NAMIK KEMAL UNIVERSITY   (Turkey)

^d MUSTAFA KEMAL UNIVERSITY   (Turkey)

Author keywords

Bacterial translocation; CAPE; Inflammatory response; Intestinal obstruction

Indexed keywords

C REACTIVE PROTEIN; CAFFEIC ACID PHENETHYL ESTER; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR; ANTIINFLAMMATORY AGENT; AUTACOID; CAFFEIC ACID DERIVATIVE; PHENETHYL ALCOHOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; DRUG EFFECT; INFLAMMATION; INTESTINE OBSTRUCTION; NONHUMAN; OXIDATIVE STRESS; RAT; TISSUE INJURY; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; INTESTINAL OBSTRUCTION; INTESTINE MUCOSA; INTRAPERITONEAL DRUG ADMINISTRATION; MICROBIOLOGY; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BACTERIAL TRANSLOCATION; CAFFEIC ACIDS; DISEASE MODELS, ANIMAL; INFLAMMATION MEDIATORS; INJECTIONS, INTRAPERITONEAL; INTESTINAL MUCOSA; INTESTINAL OBSTRUCTION; OXIDATIVE STRESS; PHENYLETHYL ALCOHOL; RATS; RATS, WISTAR;

EID: 84942082117     PISSN: 11283602     EISSN: 22840729     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. DEMIRKAN A, AKSOY M, KUZU MA, TORUNER A. The effects of indomethacine on intestinal permeability and bacterial translocation in intestinal obstruction. J Anka Univ Faculty Med 2006;259:119-127.
2. EL-AWADY S, EL-NAGAR M, EL-DAKAR M, RAGAB M, EL-NADY G. Bacterial translocation in an experimental intestinal obstruction model. C-reactive protein reliability? Acta Cir Bras 2009;24:98-106.
3. THEODOROU D, AGGELI P, MARKOGIANNAKIS H, SKOURO-LIAKOU M, ARCHONTOVASILIS F, KASTANIDOU O, BURNETAS A, XIROMERITOU V, KATSARAGAKIS S. Protection of intestinal permeability in the perioperative period. J Clin Gastroenterol 2009;4:500-504.
4. ALDEMIR M, KOKOGLU O F, GEYIK M F, BUYUKBAYRAM H. Effects of octreotide acetate and saccharomyces boulardii on bacterial translocation in an experimental intestinal loop obstruction model of rats. Tohoku J Exp Med 2002;19:1-9.
5. AKCAY MN, CAPAN MY, GUNDOGDU C, POLAT M, OREN D. Bacterial translocation in experimental intestinal obstruction. J Int Med Res 1996;24:17-26.
6. KHAN M, ELANGO C, ANSARI MA, SINGH I, SINGH AK. Caffeic acid phenethyl ester reduces neurovascu-lar inflammation and protects rat brain following transient focal cerebral ischemia. J Neurochem 2007;102:365-377.
7. RUSSO A, LONGO R, VANELLA A. Antioxidant activity of propolis: role of caffeic acid phenethyl ester and galangin. Fitoterapia 2002;73:21-29.
8. SUD'INA G F, MIRZOEVA OK, PUSHKAREVA MA, KOR-SHUNOVA GA, SUMBATYAN N V, VARFOLOMEEV SD. Caf-feic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Lett 1993;329:21-24.
9. HEPSEN I F, BAYRAMLAR H, GULTEK A, OZEN S, TILGEN F, EVEREKLIOGLU C. Caffeic acid phenethyl ester to inhibit posterior capsule opacification in rabbits. J Cataract Refract Surg 1997;23:1572-1576.
10. ILHAN A, KOLTUKSUZ U, OZEN S, UZ E, CIRALIK H, AKY-OL O. The effects of caffeic acid phenethyl ester (CAPE) on spinal cord ischemia/reperfusion injury in rabbits. Eur J Cardiothorac Surg 1999;16:458-463.
11. KOLTUKSUZ U, OZEN S, UZ E, AYDINC M, KARAMAN A, GU LTEK A, AKYOL O, GÜRSOY MH, AYDIN E. Caffeic acid phenethyl ester prevents intestinal reperfusion injury in rats. J Pediatr Surg 1999;34:1458-1462.
12. VELAZQUEZ C, NAVARRO M, ACOSTA A, ANGULO A, DOMINGUEZ Z, ROBLES R, ROBLES-ZEPEDA R, LUGO E, GOYCOOOLEA FM, VELAZQUEZ E F, ASTIAZARAN H, HER-NANDES J. Antibacterial and free-radical scavenging activities of sonoran propolis. J App Microbiol 2007;103:1747-1756.
13. POPOVA M, SILICI S, KAFTANOGLU O, BANKOVA V. Antibacterial activity of Turkish propolis and its qualitative and quantitative chemical composition. Phy-tomedicine 2005;12:221-228.
14. ECKERSON HW, ROMSO J, WYTE C, LA DU BN. The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts. Am J Hum Genet 1993;35:214-227.
15. EREL O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem 2004;37:112-119.
16. EREL O. A new automated colorimetric method for measuring total oxident status. Clin Biochem 2005;38:1103-1111.
17. VAN HOORN EC, VAN MIDDELAAR-VOSKUILEN MC, VAN LIMPT CJP, LAMB KJ, BOURITIUS H, VRIESEMA AJ, VAN LEEUWEN PA, VAN NORREN K. Preoperative supplementation with a carbohydrate mixture decreases organ dysfunction-associated risk factors. Clin Nutr 2005;224:114-123.
18. MORI S, SAWADA T, OKADA T, KUBOTA K. Erythropoi-etin and its derivative protect the intestine from severe ischemia/reperfusion injury in the rat. Surgery 2008;143:556-565.
19. CEVIKEL MH, OZGUN H, BOYLU S, DEMIRKIRAN AE, AY-DIN N, SARI C, ERKUS M. C-reactive protein may be a marker of bacterial translocation in experimental intestinal obstruction. ANZ J Surg 2004;74:900-904.
20. DEITCH EA. Simple intestinal obstruction causes bacterial translocation in man. Arch Surg 1989;124:699-701.
21. NIEUWENHUIJS VB, VERHEEM A, VAN DUIJVENBODE-BEUMER H, VISSER MR, VERHOEF J, GOOSZEN HG, AKKERMANS LM. The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth and bacterial translocation in rats. Ann Surg 1998;228:188-193.
22. BERG RD. Bacterial translocation from the gastrointestinal tract. Trends Microbiol 1995;3:149-154.
23. QUIRINO IEP, CORREIA MITD, CARDOSO VN. The impact of arginine on bacterial translocation in an intestinal obstruction model in rats. Clin Nutr 2007;26:335-340.
24. OLIVEIRA MA, LEMOS DS, DINIZ SO, COELHO J V, CARDOSO VN. Prevention of bacterial translocation using glutamine: a new strategy of investigation. Nutrition 2006;22:419-424.
25. KABAROUDIS A, PAPAZIOGAS B, KOUTELIDAKIS I, KYPARISSI-KANELLAKI M, KOUZI-KOLIAKOU K, PAPAZIOGAS T. Disruption of the small-intestine mucosal barrier after intestinal occlusion: a study with light and electron microscopy. J Invest Surg 2003;16:23-28.
26. SAMEL S, KEESE M, KLECZKA M, LANIG S, GRETZ N, HAFNER M, STURM J, POST S. Microscopy of bacterial translocation during small bowel obstruction and ischemia in vivo a new animal model. BMC Surg 2002;5:449-455.
27. ANTEQUERA R, BRETANA A, CIRAC A, BRITO A, ROMERA MA, ZA PATA R. Disruption of the intestinal barrier and bacterial translocation in an experimental model of intestinal obstruction. Acta Cient Venez 2000;51:18-26.
28. ALEXANDER J W, BOYCE ST, BABCOCK G F, GIANOTTI L, PECK MD, DUNN DL, PYLES T, CHILDRESS C P, ASH SK. The process of microbial translocation. Ann Surg 1990;212:496-510.
29. LIOLIOS A, OROPELLO JM, BENJAMIN E. Gastrointestinal complications in the intensive care unit. Clin Chest Med 1990;20:329-345.
30. AKYILDIZ M, ERSIN S, OYMACI E, DAYANGAC M, KAPKAC M, ALKANAT M. Effects of somatostatin analogues and vitamin C on bacterial translocation in an experimental intestinal obstruction model of rats. J Invest Surg 2000;213:169-173.
31. WELLS CL, MADDAUS MA, SIMMONS RL. Proposed mechanisms for the translocation of intestinal bacteria. Rev Infect Dis 1988;10:958-979.
32. BERG RD. Bacterial translocation from the gastrointestinal tract. Adv Exp Med Biol 1999;473:11-30.
33. GUREL A, ARMUTCU F, SAHIN S, SOGUT S, OZYURT H, GULEC M, KUTLU NO, AKYOL O. Protective role of al-pha-tocopherol and caffeic acid phenethyl ester on ischemia-reperfusion injury via nitric oxide and myeloperoxidase in rat kidneys. Clin Chim Acta 2004;339:33-41.